CABA
Cabaletta Bio, Inc.
There isn't enough reported data to score CABA yet.
CABA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
CABA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
CABA PE Valuation
CABA has no meaningful PE right now: it lost money over the past year.
CABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| Low |
Analysts expect CABA's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
CABA Earnings Per Share
CABA Quarterly Revenue
CABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$42.9M | -$8.3M |
| Q2 2026 | -$41.5M | -$10.9M |
| Q1 2026 | -$42.6M | -$11M |
| Q4 2025 | -$35.5M | -$12.1M |
| Q3 2025 | -$34.6M | -$14M |
| Q2 2025 | -$30.6M | -$9M |
| Q1 2025 | -$31.6M | -$6.8M |
| Q4 2024 | -$23.5M | -$6.9M |
CABA has burned cash in almost every quarter: −$163M over the past year, against −$120M the year before.
CABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +24% | +35.6M shares |
| 1 year | +94% | +90.5M shares |
CABA has 187M diluted shares, up 94% from a year ago.
CABA Net Leverage
CABA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 6.1 | Oversold |
CABA's weekly RSI is 32 (neutral) and its Stochastic is 6 (oversold).
CABA PE vs Healthcare Sector
CABA has no meaningful PE right now: it lost money over the past year.
CABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 18% below |
| 20 week MA | $2.40 | 45% below |
| 50 week MA | $2.71 | 51% below |
| 100 week MA | $2.35 | 43% below |
| 200 week MA | $7.12 | 81% below |
CABA is in a downtrend: it's below all five of its weekly moving averages, and 81% below its 200-week average.
CABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.8 | $12.3 | -11% |
| 2021 | $12.3 | $4.24 | -66% |
| 2022 | $4.24 | $8.48 | +100% |
| 2023 | $8.48 | $22.7 | +168% |
| 2024 | $22.7 | $2.29 | -90% |
| 2025 | $2.29 | $2.19 | -4.4% |
| 2026 YTD | $2.19 | $1.33 | -39% |
CABA's yearly returns have swung widely, from +168% in 2023 to −90% in 2024. It's down 39% so far in 2026.